Physician profile

Richard A Brodie

Internal Medicine · Brookline, MA

NPI 1912900473

$4,752.64

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,280.15 2019-2020
Astrazeneca Pharmaceuticals LP $810.25 2019-2021
Glaxosmithkline, LLC. $581.49 2019-2020
Amgen INC. $363.37 2019-2021
Janssen Pharmaceuticals, INC $249.18 2019
Lilly USA, LLC $225.28 2019-2021
Celgene Corporation $222.18 2019
Exactech, INC. $177.00 2021
Pfizer INC. $173.75 2019
Allergan, INC. $132.49 2019
Biohaven Pharmaceuticals, INC. $122.79 2021
Takeda Pharmaceuticals U.S.A., INC. $107.93 2019
E.R. Squibb & Sons, L.L.C. $101.28 2019
Novo Nordisk INC $85.53 2019-2020
Boehringer Ingelheim Pharmaceuticals, INC. $77.51 2019-2020
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Endo Pharmaceuticals INC. $21.72 2019
Ironwood Pharmaceuticals, INC $20.74 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Richard A Brodie

$4,752.64

in general payments reported 2019-2025

Years
2019-2021
Top company
Abbvie INC.

https://glasscript.com/doctor/358890/richard-a-brodie

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.